Insights

LTI Grants in a Volatile Environment

by Chris Havey on January 4, 2021

Client Alerts

Read More

How and Why Pre-Commercial Biotech CEO Pay is Different – Part Three: East Coast vs. West Coast

by Jim Heim on October 5, 2020

Thought Leadership

In this four-part series, we examine the current state of pre-commercial biotech CEO pay, how it is tailored to the sector, and what drives differences between companies.

Read More

2020 Meridian Corporate Governance and Incentive Design Survey

by Carrie Guenther on October 2, 2020

Surveys

The Survey covers key board governance practices, compensation-related proxy disclosures, and annual and long-term incentive design practices. This information allows companies to benchmark their board governance practices, proxy disclosures and compensation program design against market practices.

Read More

Meridian Webinar: COVID-19’s Impact on Incentive Plans

by Andrew Conradi on September 23, 2020

Video

COVID-19 has altered fundamental priorities for the year and significantly affected many companies’ ability to achieve the annual incentive plan and/or performance-contingent long-term incentive plan goals that were set prior to current circumstances.

Read More

How and Why Pre-Commercial Biotech CEO Pay is Different – Part Two: Founders vs. Non-Founders

by Jim Heim on August 21, 2020

Thought Leadership

In this four-part series, we examine the current state of pre-commercial biotech CEO pay, how it is tailored to the sector, and what drives differences between companies.

Read More

The Meridian Advantage

We invite you to learn about what makes Meridian unique.

Contact Us